Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides

This publication has 100 references indexed in Scilit:

• Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
  Science, 1991
• TOXICITY OF RAPAMYCIN—A COMPARATIVE AND COMBINATION STUDY WITH CYCLOSPORINE AT IMMUNOTHERAPEUTIC DOSAGE IN THE RAT
  Transplantation, 1991
• Signalling in B cells
  Immunology Today, 1991
• The B-cell antigen receptor complex
  Immunology Today, 1991
• Incorporation of Acetate, Propionate, and Methionine into Rapamycin by Streptomyces hygroscopicus
  Journal of Natural Products, 1991
• Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.
  Proceedings of the National Academy of Sciences, 1990
• Role of the CD28 receptor in T-cell activation
  Immunology Today, 1990
• A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin
  Nature, 1989
• Human brain tumor xenografts in nude mice as a chemotherapy model
  European Journal of Cancer and Clinical Oncology, 1983
• Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.
  The Journal of Antibiotics, 1975